These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11270846)

  • 1. Evaluation of thin-layer chromatography methods for laxative detection.
    Duncan A; Phillips IJ
    Ann Clin Biochem; 2001 Jan; 38(Pt 1):64-6. PubMed ID: 11270846
    [No Abstract]   [Full Text] [Related]  

  • 2. A tale of two drug testing technologies: GC-MS and LC-MS/MS.
    Mikel C; Pesce A; West C
    Pain Physician; 2010; 13(1):91-2. PubMed ID: 20119467
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of reported drug use and urinalysis in the assessment of drug use.
    Jain R; Tripathi BM; Singh R
    Natl Med J India; 2001; 14(5):315-6. PubMed ID: 11767230
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of the abuse of magnesium and stimulant laxatives.
    Duncan A; Cameron A; Stewart MJ; Russell RI
    Ann Clin Biochem; 1991 Nov; 28 ( Pt 6)():568-73. PubMed ID: 1776806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

  • 8. A rapid high-performance thin-layer chromatographic urine screen for laxative abuse.
    Perkins SL; Livesey JF
    Clin Biochem; 1993 Jun; 26(3):179-81. PubMed ID: 8330386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferences with urine drug screens.
    Herring C; Muzyk AJ; Johnston C
    J Pharm Pract; 2011 Feb; 24(1):102-8. PubMed ID: 21507878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cautionary note on use of INSTANT-VIEW M-1 to avoid incomplete reaction].
    Tsuda N
    Chudoku Kenkyu; 2013 Dec; 26(4):289-91. PubMed ID: 24483006
    [No Abstract]   [Full Text] [Related]  

  • 11. Urine drug screens.
    Cockrell K
    Indiana Med; 1991 Jun; 84(6):416-7. PubMed ID: 1918913
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urine testing in the treatment of opiate addiction].
    Ege PP
    Ugeskr Laeger; 2003 Mar; 165(13):1346-8. PubMed ID: 12703279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug of abuse screening in urine in emergency situations; useful or not?].
    De Wit LE; Dekker D
    Ned Tijdschr Geneeskd; 2021 Feb; 164():. PubMed ID: 33651500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection of laxative abuse.
    Morton J
    Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():107-8. PubMed ID: 3827173
    [No Abstract]   [Full Text] [Related]  

  • 15. Factitious diarrhea induced by stimulant laxatives: accuracy of diagnosis by a clinical reference laboratory using thin layer chromatography.
    Shelton JH; Santa Ana CA; Thompson DR; Emmett M; Fordtran JS
    Clin Chem; 2007 Jan; 53(1):85-90. PubMed ID: 17110471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. I Have Never Used Methamphetamine, But My Urinalysis Says I Do.
    Sethi R; Din A; McAllister R; Lester A
    Prim Care Companion CNS Disord; 2018 Oct; 20(5):. PubMed ID: 30407755
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.
    West R; Pesce A; West C; Crews B; Mikel C; Almazan P; Rosenthal M; Latyshev S
    Pain Physician; 2010; 13(1):71-8. PubMed ID: 20119465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 19. A screening method for establishing laxative abuse.
    de Wolff FA; de Haas EJ; Verweij M
    Clin Chem; 1981 Jun; 27(6):914-7. PubMed ID: 6894566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of thin-layer chromatography for drug control. Use in laxative drug combinations].
    Rousselet R; Paris RR
    J Pharm Belg; 1971; 26(5):568-76. PubMed ID: 5137703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.